Oxford Cannabinoid Technologies Overview

  • Founded
  • 2017
Founded
  • Status
  • Public
  • Employees
  • 2
Employees
  • Stock Symbol
  • OCTP
Stock Symbol
  • Share Price
  • $0.01
  • (As of Monday Closing)

Oxford Cannabinoid Technologies General Information

Description

Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development strategy that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Stock Exchange
LON
Primary Office
  • 1 Maddox Street
  • London W1S 2PZ
  • England, United Kingdom
+44 020 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Oxford Cannabinoid Technologies Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.01 $0.01 $0.01 - $0.11 $10.8M 960M 4.02M

Oxford Cannabinoid Technologies Financials Summary

In Thousands,
USD
TTM 30-Nov-2021 FY 2021 31-May-2021 FY 2020 31-May-2020 FY 2019 31-May-2019
EV 9,868 33,888
Revenue 0 0 0 0
EBITDA (6,677) (4,237) (2,834) (3,712)
Net Income (6,159) (4,299) (2,680) (3,400)
Total Assets 17,254 21,569 1,638 2,942
Total Debt 74 247 132 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Oxford Cannabinoid Technologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Oxford Cannabinoid Technologies‘s full profile, request access.

Request a free trial

Oxford Cannabinoid Technologies Executive Team (7)

Name Title Board Seat Contact Info
John Lucas Ph.D Chief Executive Officer & Board Member
Karen Lowe Chief Financial Officer, Finance & Board Member
Eugenia Shostak Chief Financial Officer
Clarissa Sowemimo-Coker Chief Operating Officer, Operations & Board Member
Valentino Parravicini Chief Scientific Officer
You’re viewing 5 of 7 executive team members. Get the full list »

Oxford Cannabinoid Technologies Board Members (13)

Name Representing Role Since
Bishrut Mukherjee Self Board Member 000 0000
Charanjit Dhillon Oxford Cannabinoid Technologies Board Member 000 0000
Cheryl Dhillon Oxford Cannabinoid Technologies Board Member 000 0000
Clarissa Sowemimo-Coker Oxford Cannabinoid Technologies Chief Operating Officer, Operations & Board Member 000 0000
Hee-Dong Kim Kingsley Capital Partners Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Oxford Cannabinoid Technologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oxford Cannabinoid Technologies Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Oxford Cannabinoid Technologies‘s full profile, request access.

Request a free trial